VY4 Stock Chart & Stats
€1.98
€0.02(1.05%)
At close: 4:00 PM EST
€1.98
€0.02(1.05%)
Day’s Range― - ―
52-Week Range€1.09 - €2.41
Previous CloseN/A
Volume0.00
Average Volume (3M)150.00
Market Cap
€277.26M
Enterprise Value€320.28
Total Cash (Recent Filing)€186.57M
Total Debt (Recent Filing)€166.38M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Nov 10, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding260,300,000
10 Day Avg. Volume351
30 Day Avg. Volume150
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.53
Price to Sales (P/S)0.62
P/FCF Ratio10.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.07Price Target Upside55.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)€808.97M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthLarge unrestricted cash and zero debt provide durable financial flexibility: supports continued share repurchases, funds restructurings or opportunistic M&A, and cushions operational volatility. This conservatively leveraged position reduces refinancing risk and underpins multi-month strategic execution.
Improving Cash GenerationPositive trailing‑twelve‑month operating and free cash flow signal that core operations can generate cash despite accounting losses. Durable cash generation supports reinvestment, debt-light growth and capital returns, and reduces reliance on external financing across the next several quarters.
U.S. Medical Cannabis ExpansionAcquiring Parallel assets creates a structural growth path into U.S. medical markets with 56 stores and cultivation capacity, diversifying geography and revenue mix. If consolidated, the platform offers scale benefits, distribution synergies and the potential to materially lift long‑term revenue cadence.
Bears Say
Revenue ContractionSustained top‑line weakness across cannabis and liquor retail limits margin leverage and slows recovery of profitability. Continued revenue contraction forces reliance on cost cuts and one‑time gains to meet targets, making durable earnings improvements dependent on reversing demand trends or expanding new revenue sources.
Cannabis Ops Margin CollapseSevere margin erosion in cannabis operations driven by production ramp inefficiencies (Jeeter) demonstrates execution risk. Persistent production cost issues and lost B2B deliveries can depress segment returns for months, requiring operational fixes before the business regains sustainable profitability.
Quarterly Free Cash Flow VolatilityAlthough TTM free cash flow is positive, quarter‑level negative FCF and timing items (incentives, cash in transit) show uneven cash conversion. This volatility can constrain investment pacing, limit cushion for unexpected costs, and complicate consistent capital returns or reinvestment over coming quarters.
SNDL News
VY4 FAQ
What was Sndl Inc.’s price range in the past 12 months?
Sndl Inc. lowest stock price was €1.08 and its highest was €2.41 in the past 12 months.
What is Sndl Inc.’s market cap?
Sndl Inc.’s market cap is €277.26M.
When is Sndl Inc.’s upcoming earnings report date?
Sndl Inc.’s upcoming earnings report date is Nov 10, 2026 which is in 102 days.
How were Sndl Inc.’s earnings last quarter?
Sndl Inc. released its earnings results on Jul 28, 2026. The company reported -€0.019 earnings per share for the quarter, missing the consensus estimate of -€0.003 by -€0.016.
Is Sndl Inc. overvalued?
According to Wall Street analysts Sndl Inc.’s price is currently Undervalued.
Does Sndl Inc. pay dividends?
Sndl Inc. does not currently pay dividends.
What is Sndl Inc.’s EPS estimate?
Sndl Inc.’s EPS estimate is -0.01.
How many shares outstanding does Sndl Inc. have?
Sndl Inc. has 260,300,000 shares outstanding.
What happened to Sndl Inc.’s price movement after its last earnings report?
Sndl Inc. reported an EPS of -€0.019 in its last earnings report, missing expectations of -€0.003. Following the earnings report the stock price went down -0.842%.
Which hedge fund is a major shareholder of Sndl Inc.?
Currently, no hedge funds are holding shares in DE:VY4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€3.07 (55.18% Upside)
€3.07 (55.18% Upside)
Blogger Sentiment
Neutral
DE:VY4 Sentiment 50%
Sector Average 62%
Sector Average 62%
Insider Transactions
Bought Shares
Worth €85.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.89%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.32%
Trailing 12-Months
Company Description
Sndl Inc.
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
VY4 Company Deck
VY4 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The quarter presented a mixed picture: operational performance was challenged with declines in revenue, gross profit and segment-level profitability (notably in cannabis operations and liquor retail), driven by market softness and production ramp inefficiencies (Jeeter). Offsetting these headwinds, SNDL entered transformational capital and strategic positions — strong liquidity (CAD 183.2M), zero debt, accelerated share repurchases (~7% reduction in shares outstanding), deployment of profit enhancement initiatives (>CAD 20M expected), modest improvement in free cash flow, and the completion of a major parallel restructuring milestone that opens access to a sizeable U.S. medical cannabis platform with material upside. Given substantial near-term operational challenges balanced against meaningful balance sheet strength and strategic optionality, the call’s tone is cautiously constructive but mixed.View all DE:VY4 earnings summariesVY4 Stock 12 Month Forecast
Average Price Target
€3.07
▲(55.18% Upside)